Literature DB >> 910721

Effect of procainamide, propranolol and verapamil on mechanism of tachycardia in patients with chronic recurrent ventricular tachycardia.

H J Wellens, F W Bär, K I Lie, D R Düren, H J Dohmen.   

Abstract

The effect of short-term intravenous administration of procainamide (12 patients), propranolol (4 patients) and verapamil (4 patients) was studied in 12 patients with chronic recurrent sustained ventricular tachycardia. In all patients tachycardia could reproducibly be initiated and terminated with programmed electrical stimulation of the heart. Procainamide (1) lengthened the effective refractory period of the right ventricle, (2) affected the tachycardia zone, (3) reduced ventricular rate during tachycardia, and (4) lengthened the interval between the tachycardia-initiating premature ventricular beat and the first QRS complex of tachycardia. No effect on the refractory period of the right ventricle or the mechanism of tachycardia was seen after administration of propranolol or verapamil. Apart from their therapeutic implications these data suggest that it may be possible to use drugs to study mechanisms of ventricular tachycardia in the human heart.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 910721     DOI: 10.1016/0002-9149(77)90074-1

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


  14 in total

Review 1.  Antiarrhythmic drug classifications. A critical appraisal of their history, present status, and clinical relevance.

Authors:  S Nattel
Journal:  Drugs       Date:  1991-05       Impact factor: 9.546

Review 2.  Role of calcium antagonists in cardiovascular therapy.

Authors:  H Dargie; E Rowland; D Krikler
Journal:  Br Heart J       Date:  1981-07

3.  Response of recurrent sustained ventricular tachycardia to verapamil.

Authors:  B Belhassen; H H Rotmensch; S Laniado
Journal:  Br Heart J       Date:  1981-12

4.  Effects of propranolol on ventricular repolarization in man.

Authors:  K Endresen; J P Amlie
Journal:  Eur J Clin Pharmacol       Date:  1990       Impact factor: 2.953

5.  Suppression of ventricular arrhythmias in man by d-propranolol independent of beta-adrenergic receptor blockade.

Authors:  K T Murray; C Reilly; R P Koshakji; D M Roden; M D Lineberry; A J Wood; L A Siddoway; J T Barbey; R L Woosley
Journal:  J Clin Invest       Date:  1990-03       Impact factor: 14.808

6.  Electrophysiological effects of lorcainide, a new antiarrhythmic drug. Observations in patients with and without pre-excitation.

Authors:  F W Bär; J Farré; D Ross; E J Vanagt; A P Gorgels; H J Wellens
Journal:  Br Heart J       Date:  1981-03

Review 7.  Verapamil in arrhythmia.

Authors:  D M Krikler
Journal:  Br J Clin Pharmacol       Date:  1986       Impact factor: 4.335

8.  Effects of verapamil on ventricular tachycardias possibly caused by reentry, automaticity, and triggered activity.

Authors:  R J Sung; W A Shapiro; E N Shen; F Morady; J Davis
Journal:  J Clin Invest       Date:  1983-07       Impact factor: 14.808

Review 9.  The electrocardiogram in the assessment of the effect of drugs on cardiac arrhythmias.

Authors:  D S Reid
Journal:  Br J Clin Pharmacol       Date:  1978-12       Impact factor: 4.335

Review 10.  Calcium antagonists. Clinical use in the treatment of arrhythmias.

Authors:  B N Singh; K Nademanee; S H Baky
Journal:  Drugs       Date:  1983-02       Impact factor: 9.546

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.